Correlation Between IMAC Holdings and DiaMedica Therapeutics
Can any of the company-specific risk be diversified away by investing in both IMAC Holdings and DiaMedica Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining IMAC Holdings and DiaMedica Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between IMAC Holdings and DiaMedica Therapeutics, you can compare the effects of market volatilities on IMAC Holdings and DiaMedica Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in IMAC Holdings with a short position of DiaMedica Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of IMAC Holdings and DiaMedica Therapeutics.
Diversification Opportunities for IMAC Holdings and DiaMedica Therapeutics
-0.53 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between IMAC and DiaMedica is -0.53. Overlapping area represents the amount of risk that can be diversified away by holding IMAC Holdings and DiaMedica Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on DiaMedica Therapeutics and IMAC Holdings is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on IMAC Holdings are associated (or correlated) with DiaMedica Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of DiaMedica Therapeutics has no effect on the direction of IMAC Holdings i.e., IMAC Holdings and DiaMedica Therapeutics go up and down completely randomly.
Pair Corralation between IMAC Holdings and DiaMedica Therapeutics
Given the investment horizon of 90 days IMAC Holdings is expected to under-perform the DiaMedica Therapeutics. In addition to that, IMAC Holdings is 1.08 times more volatile than DiaMedica Therapeutics. It trades about -0.14 of its total potential returns per unit of risk. DiaMedica Therapeutics is currently generating about 0.11 per unit of volatility. If you would invest 430.00 in DiaMedica Therapeutics on August 28, 2024 and sell it today you would earn a total of 32.00 from holding DiaMedica Therapeutics or generate 7.44% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
IMAC Holdings vs. DiaMedica Therapeutics
Performance |
| Timeline |
| IMAC Holdings |
| DiaMedica Therapeutics |
IMAC Holdings and DiaMedica Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with IMAC Holdings and DiaMedica Therapeutics
The main advantage of trading using opposite IMAC Holdings and DiaMedica Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if IMAC Holdings position performs unexpectedly, DiaMedica Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in DiaMedica Therapeutics will offset losses from the drop in DiaMedica Therapeutics' long position.| IMAC Holdings vs. Heartbeam | IMAC Holdings vs. EUDA Health Holdings | IMAC Holdings vs. Nutex Health | IMAC Holdings vs. Healthcare Triangle |
| DiaMedica Therapeutics vs. Eliem Therapeutics | DiaMedica Therapeutics vs. HCW Biologics | DiaMedica Therapeutics vs. Scpharmaceuticals | DiaMedica Therapeutics vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Other Complementary Tools
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |